Copyright
©The Author(s) 2022.
World J Virol. Sep 25, 2022; 11(5): 321-330
Published online Sep 25, 2022. doi: 10.5501/wjv.v11.i5.321
Published online Sep 25, 2022. doi: 10.5501/wjv.v11.i5.321
Table 1 Coronavirus disease 2019 disease severity score
| Disease severity | Definition |
| Asymptomatic | No symptoms at all during the course of COVID-19 |
| Mild disease | Symptoms that did not require hospital admission; if hospitalization was required, the indication was for a cause other than the management of COVID-19 associated symptoms or signs |
| Moderate disease | Symptoms that required inpatient management of COVID-19 associated symptoms, but without the need for PICU care |
| Severe disease | Symptoms that required PICU care for COVID-19 related signs and symptoms |
Table 2 Characteristics of pediatric oncology patients with coronavirus disease 2019
| Patient characteristics | Number | Percentage (%) |
| Sex | ||
| Male | 24 | 60 |
| Female | 16 | 40 |
| Age | ||
| 1-6 yr | 28 | 70 |
| 6-12 yr | 5 | 12.5 |
| 12-14 yr | 7 | 17.5 |
| Primary disease | ||
| Acute lymphoblastic leukemia | 30 | 75 |
| Acute myeloid leukemia | 2 | 5 |
| Neuroblastoma | 2 | 5 |
| Rhabdomyosarcoma | 2 | 5 |
| CNS tumors | 2 | 5 |
| Hodgkin lymphoma | 2 | 5 |
Table 3 Laboratory and radiological details for coronavirus disease 2019 in our oncology patients
| Parameters | Numbers | Percentage (%) |
| WBC count | ||
| Leukopenia < 4000 | 16 | 40 |
| Normal WBC count | 20 | 50 |
| Leukocytosis > 16000 | 4 | 10 |
| Lymphocytes count | ||
| Lymphopenia | 23 | 57.5 |
| Normal count | 17 | 42.5 |
| Lymphocytosis | 0 | 0 |
| Neutrophil count | ||
| Severe neutropenia | 10 | 25 |
| Mild-Moderate neutropenia | 10 | 25 |
| Normal count | 16 | 40 |
| Neutrophilia | 4 | 10 |
| CRP titer | ||
| Negative < 6 | 3 | 7.5 |
| Positive 6 | 37 | 92.5 |
| D-Dimer | ||
| Positive | 6 | 15 |
| Negative | 34 | 85 |
| IgG level | ||
| < 700 mg/dL | 9 | 22.5 |
| > 700 mg/dL | 31 | 77.5 |
| Chest X-ray findings | ||
| Normal chest X-ray | 18 | 45 |
| Perihilar infiltrates | 12 | 30 |
| Bilateral patchy consolidation | 10 | 25 |
| High-resolution chest CT scan findings | ||
| Bilateral infiltration > 25% | 8 | 20 |
| Bilateral infiltration 25%-50% | 2 | 5 |
| Bilateral infiltration > 50% | 0 | 0 |
Table 4 Details of the clinical course of coronavirus disease 2019 in oncology patients
| Parameters | Number | Percentage |
| Presenting symptoms | ||
| Fever | 24 | 60 |
| Cough | 15 | 37.5 |
| Sore throat | 3 | 7.5 |
| Dyspnea | 2 | 5 |
| Diarrhea | 2 | 5 |
| Disease severity | ||
| Asymptomatic | 10 | 25 |
| Mild disease | 20 | 50 |
| Moderate disease | 8 | 20 |
| Severe disease | 2 | 5 |
| Place of care | ||
| Home isolation | 12 | 30 |
| COVID-19 ward | 26 | 65 |
| PICU | 2 | 5 |
| Treatment required | ||
| No treatment | 10 | 25 |
| IV antibiotic | 24 | 60 |
| Azithromycin | 30 | 75 |
| Vitamins | 30 | 75 |
| Dexamethasone | 26 | 65 |
| Oxygen support | 4 | 10 |
| CPAP | 2 | 5 |
| IVIG | 9 | 22.5 |
- Citation: Qatawneh MA, Altarawneh M, Alhazaimeh R, Jazazi M, Jarrah O, Shorman A, Alsadah L, Mustafa M. Manifestations of COVID-19 infection in children with malignancy: A single-center experience in Jordan. World J Virol 2022; 11(5): 321-330
- URL: https://www.wjgnet.com/2220-3249/full/v11/i5/321.htm
- DOI: https://dx.doi.org/10.5501/wjv.v11.i5.321
